SecurityMETC / Ramaco Resources, Inc. (75134P303)
President and CEOBauersachs Michael Dale
Institutional Owners54
Institutional Shares34,048,261 - 84.95%
Common Stock Shares Outstanding40,082,467 shares (as of 2018-06-30)
Institutional Value$ 238,268,000 USD

Institutional Stock Ownership and Shareholders

METC / Ramaco Resources, Inc. Institutional Ownership

Ramaco Resources, Inc. (NASDAQ:METC) has 54 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 34,048,261 shares. Largest shareholders include Yorktown Energy Partners IX, L.P., Ecp Controlco, Llc, Yorktown Energy Partners XI, L.P., Yorktown Energy Partners X, L.P., Anchor Bolt Capital, LP, Foundry Partners, LLC, Alyeska Investment Group, L.P., Mangrove Partners, BlackRock Inc., and Vanguard Group Inc.
Ramaco Resources, Inc. (NASDAQ:METC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR Man Group plc 239,095 193,983 -18.87 1,719 1,351 -21.41
2018-02-14 13F-HR GLG LLC 171,554 171,554 0.00 1,137 1,180 3.78
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 46,402 52,975 14.17 333 368 10.51
2018-08-14 13F-HR JP Morgan Chase & Co 1,220 272,415 22,229.10 9 1,896 20,966.67
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 430 430 0.00 3 3 0.00
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 968 733 -24.28 7 5 -28.57
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 4,204 1,253 -70.20 31 8 -74.19
2018-08-09 13F-HR GSA CAPITAL PARTNERS LLP 10,779 0 -100.00 78 0 -100.00
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 122,800 122,800 0.00 883 855 -3.17
2018-05-11 13F-HR CITIGROUP INC 911 1,032 13.28 6 7 16.67
2018-07-19 13F-HR Foundry Partners, LLC 366,500 366,675 0.05 2,635 2,552 -3.15
2018-07-24 13F-HR Unigestion Holding Sa 125,036 870
2018-08-14 13F-HR Anchor Bolt Capital, LP 1,269,354 835,160 -34.21 9,127 5,813 -36.31
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 3,925 3,896 -0.74 28 27 -3.57
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 14,601 20,420 39.85 105 142 35.24
2018-09-18 13F-HR/A NORTHERN TRUST CORP 63,121 79,943 26.65 454 557 22.69
2018-08-06 13F-HR TORONTO DOMINION BANK 542 4
2018-08-14 13F-HR MORGAN STANLEY 19,370 20,199 4.28 140 140 0.00
2018-08-15 13F-HR GeoSphere Capital Management 15,716 109
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 0 98,578 0 686
2018-08-10 13F-HR CITIGROUP INC 1,032 0 -100.00 7 0 -100.00
2018-08-14 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 1,432 1,432 0.00 10 10 0.00
2018-08-14 13F-HR Weiss Multi-Strategy Advisers LLC 125,000 25,326 -79.74 899 176 -80.42
2018-08-14 13F-HR Yorktown Energy Partners IX, L.P. 14,771,525 14,771,525 0.00 106,207 102,810 -3.20
2018-08-14 13F-HR Yorktown Energy Partners XI, L.P. 5,587,128 5,587,128 0.00 40,171 38,886 -3.20
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 1,303 189 -85.50 9,369 1,315 -85.96
2018-08-14 13F-HR HIGHBRIDGE CAPITAL MANAGEMENT LLC 46,292 0 -100.00 333 0 -100.00
2018-08-14 13F-HR Dynamic Technology Lab Private Ltd 11,701 0 -100.00 84 0 -100.00
2018-08-13 13F-HR CORSAIR CAPITAL MANAGEMENT, L.P. 56,933 0 -100.00 409 0 -100.00
2018-08-14 13F-HR STATE STREET CORP 101,952 99,093 -2.80 734 689 -6.13
2018-08-14 13F-HR UBS Group AG 455 1,851 306.81 3 13 333.33
2018-08-14 13F-HR BARCLAYS PLC 1,567 1,042 -33.50 11 7 -36.36
2018-08-08 13F-HR Glassman Wealth Services 28 0
2018-08-14 13F-HR ROYAL BANK OF CANADA 204 26 -87.25 1 0 -100.00
2018-08-09 13F-HR BlackRock Inc. 313,669 308,340 -1.70 2,256 2,147 -4.83
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 6,800 6,800 0.00 49 47 -4.08
2018-08-14 13F-HR DEUTSCHE BANK AG\ 6,577 9,504 44.50 46 66 43.48
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 14,326 14,295 -0.22 103 99 -3.88
2018-08-14 13F-HR Waratah Capital Advisors Ltd. 65,365 0 -100.00 470 0 -100.00
2018-08-10 13F-HR Legal & General Group Plc 1,657 361 -78.21 12 3 -75.00
2018-08-14 13F-HR VANGUARD GROUP INC 259,277 291,247 12.33 1,864 2,027 8.74
2018-02-14 13F-HR GLG Partners LP 74,901 62,479 -16.58 497 430 -13.48
2018-08-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 15,716 109
2018-08-14 13F-HR Alyeska Investment Group, L.P. 594,643 356,062 -40.12 4,275 2,478 -42.04
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,600 9,600 0.00 69 67 -2.90
2018-08-14 13F-HR CREDIT SUISSE AG/ 27,811 16,099 -42.11 200 112 -44.00
2018-08-14 13F-HR Triarii Capital Management Lp 326,614 149,618 -54.19 2,348 1,041 -55.66
2018-07-19 13F-HR HUNTINGTON NATIONAL BANK 1,000 1,000 0.00 7 7 0.00
2018-08-08 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 25,076 25,979 3.60 181 181 0.00
2018-08-06 13F-HR STRS OHIO 1,800 0 -100.00 12 0 -100.00
2018-08-14 13F-HR KINGDON CAPITAL MANAGEMENT, L.L.C. 198,639 1,383
2018-08-15 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 38 38 0.00 0 0
2018-08-14 13F-HR Williams Jones & Associates LLC 54,300 45,960 -15.36 390 320 -17.95
2018-08-14 13F-HR MANGROVE PARTNERS 291,890 308,623 5.73 2,099 2,148 2.33
2018-08-14 13F-HR Yorktown Energy Partners X, L.P. 3,692,881 3,692,881 0.00 26,552 25,702 -3.20
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 104 1
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 906 2,167 139.18 7 15 114.29
2018-08-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 10,652 10,063 -5.53 77 70 -9.09
2018-08-14 13F-HR Ecp Controlco, Llc 5,631,349 5,631,349 0.00 40,489 39,194 -3.20
2018-08-14 13F-HR TEACHERS ADVISORS INC 13,771 15,766 14.49 99 110 11.11
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 1,073 4,591 327.87 8 32 300.00

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

Ramaco Resources Inc. (METC) CEO Mike Bauersachs on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Good day, ladies and gentlemen, and welcome to the Ramaco Resources, Inc. Second Quarter 2018 Earnings Conference Call [Operator Instructions]

5 Stocks Trading Under $10 With Massive Upside Potential

2018-06-09 247wallst
While Most of Wall Street focuses on large and mega cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy. Many of the biggest companies, especially the technology giants, trade in the low to mid hundreds, and all the way up to over $1,000 per share. At those steep prices, it’s pretty hard to get any decent share count leverage. (49-1)

Why Coal Is Back From the Dead: 4 Stocks to Buy Now

2018-06-07 247wallst
There was a time, not all that long ago, when some of the hottest stocks to buy were coal stocks. Between demand for energy and for the metallurgical coal used in making steel, demand was super-high, not only here, but around the world as well. That all changed, and as recently as just a few years ago, the industry was on life support, especially when candidate Hillary Clinton famously declared on the campaign trail “We’re going to put a lot of coal miners and coal companies out of business. (27-0)

Big U.S. banks are back embracing the coal industry

2018-06-01 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com (54-0)

Think the Big Banks Have Abandoned Coal? Think Again - The New York Times

2018-05-29 nytimes
An environmental group’s analysis shows the five largest United States banks have started lending to coal companies again now that they’re out of bankruptcy. (54-0)

Ramaco's (METC) CEO Mike Bauersachs on Q1 2018 Results - Earnings Call Transcript

2018-05-16 seekingalpha
Good day, ladies and gentlemen, and welcome to the Ramaco Resources, Inc. First Quarter 2018 Earnings Conference Call. [Operator Instructions] (1-0)

FOCUS-Two U.S. coal miners see growth amid sector's gloom

2018-05-02 reuters
(Reuters) - U.S. electric utilities are expected to shut hundreds more of their coal-fired power generators in the coming years, extending a long trend away from coal and toward natural gas that has cast a pall over the mining industry. (12-0)

Ramaco Resources' (METC) CEO Mike Bauersachs on Q4 2017 Results - Earnings Call Transcript

2018-03-22 seekingalpha
Operator Good day, ladies and gentlemen, and welcome to the Ramaco Resources, Inc. Fourth Quarter 2017 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call may be recorded. I would now like to introduce your host for today's conference, Chief Accounting Officer, Mr. Michael Windisch. Mr. Windisch, you may begin. (1-0)

CUSIP: 75134P303